Andrew Loblaw

Jan 16, 2025 | nature.com | Laurence H. Klotz |Andrew Loblaw

AbstractWe sought to determine, in a prospective long term cohort, the prognostic value of negative MR imaging with respect to upgrading and need for intervention in men on AS. A long term prospective single centre study of men on Active surveillance with MR imaging. Primary outcome was upgrading on biopsy and rate of intervention. After incorporation of MRI into the AS protocol in 2013, men with negative imaging underwent systematic biopsy only for cause.

Oct 9, 2024 | europeanurology.com | Andrew Loblaw

Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes Platinum Priority – Editorial | Referring to the article published on pp.

Feb 2, 2024 | redjournal.org | Andrew Loblaw

1 Onal C Elmali A Guler OC In Regard to Ong et al. Int J Radiat Oncol Biol Phys. 119: 1021-1022 for taking interest in our recent work. 2 Ong WL Cheung P Chung H et al. To boost or not to boost: Pooled analyses from 2-fraction SABR trials for localized prostate cancer. Int J Radiat Oncol Biol Phys. 117: 1153-1162 The FLAME trial showed the benefits of focal boost to the dominant intraprostatic lesions (DIL) in conventional fractionated radiation therapy.